A detailed history of Susquehanna International Group, LLP transactions in Danaher Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 193,497 shares of DHR stock, worth $44.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
193,497
Previous 165,574 16.86%
Holding current value
$44.6 Million
Previous $41.4 Million 30.03%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $6.68 Million - $7.84 Million
27,923 Added 16.86%
193,497 $53.8 Million
Q2 2024

Aug 15, 2024

SELL
$235.51 - $267.98 $5.4 Million - $6.14 Million
-22,924 Reduced 12.16%
165,574 $41.4 Million
Q1 2024

May 07, 2024

SELL
$224.58 - $256.19 $11.4 Million - $13 Million
-50,553 Reduced 21.15%
188,498 $47.1 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $41.7 Million - $52.5 Million
-225,082 Reduced 48.5%
239,051 $55.3 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $61.9 Million - $70.5 Million
265,403 Added 133.55%
464,133 $115 Million
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $34.3 Million - $39 Million
-152,258 Reduced 43.38%
198,730 $47.7 Million
Q1 2023

May 16, 2023

BUY
$239.75 - $277.0 $12.2 Million - $14.1 Million
50,995 Added 17.0%
350,988 $88.5 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $51.8 Million - $60.6 Million
214,602 Added 251.32%
299,993 $79.6 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $23.7 Million - $144 Million
-95,750 Reduced 52.86%
85,391 $22.1 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $5.61 Million - $7.09 Million
-23,650 Reduced 11.55%
181,141 $45.9 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $9.97 Million - $12.2 Million
38,744 Added 23.33%
204,791 $60.1 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $8.37 Million - $9.42 Million
-28,644 Reduced 14.71%
166,047 $54.6 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $20.3 Million - $24.8 Million
-74,726 Reduced 27.74%
194,691 $59.3 Million
Q2 2021

Aug 11, 2021

BUY
$225.08 - $271.69 $30 Million - $36.2 Million
133,189 Added 97.77%
269,417 $72.3 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $20.9 Million - $24.2 Million
-98,268 Reduced 41.91%
136,228 $30.7 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $38.2 Million - $44.2 Million
179,875 Added 329.31%
234,496 $52.1 Million
Q3 2020

Nov 16, 2020

SELL
$177.16 - $215.33 $3.14 Million - $3.81 Million
-17,709 Reduced 24.48%
54,621 $11.8 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $7.88 Million - $10.8 Million
-61,262 Reduced 45.86%
72,330 $12.8 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $3.66 Million - $5.1 Million
-30,185 Reduced 18.43%
133,592 $18.5 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $21.3 Million - $24.5 Million
159,782 Added 3999.55%
163,777 $25.1 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $1.21 Million - $1.31 Million
-8,944 Reduced 69.12%
3,995 $577,000
Q2 2019

Aug 16, 2019

BUY
$124.88 - $143.73 $234,274 - $269,637
1,876 Added 16.96%
12,939 $1.85 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $311,825 - $358,893
2,497 Added 29.15%
11,063 $1.58 Million
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $65,059 - $69,893
-677 Reduced 7.32%
8,566 $845,000
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $4.55 Million - $5.13 Million
-49,398 Reduced 84.24%
9,243 $905,000
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $4.36 Million - $4.84 Million
51,116 Added 679.28%
58,641 $5.44 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $596,657 - $665,586
7,525
7,525 $645,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.